Willem J. Remme - Concepedia

Author

Willem J. Remme

Also Known As

FOR THE PIMOBENDAN-ENALAPRIL STUDY GROUP, Remme, WJ, Sunil V Rao, Sunil V. Rao, W J Remme, W REMME, W Remme, W. J. REMME, W. J. Remme, W.J Remme

232

Publications

29.4K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Flevoziekenhuis Pitié-Salpêtrière Hospital Sorbonne Université Lille’s Cardiology Hospital

About

Willem J. Remme is an author at Erasmus University Rotterdam specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	48	8.4K
2	Public Health	11	12	1K
3	Health Sciences	5	5	1.9K
4	Education	1	1	2.9K
5	Anesthesia	1	1	21

Willem J. Remme

Publications

28K

Citations

H-Index

Page 1

	Year	Citations
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Bertram Pitt, Faı̈ez Zannad, Willem J. Remme, New England Journal of Medicine	1999	9K
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction Bertram Pitt, Willem J. Remme, Faı̈ez Zannad, New England Journal of Medicine	2003	4.9K
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Bertram Pitt, Faı̈ez Zannad, Willem J. Remme, Survey of Anesthesiology Heart FailureEducationResearch EvaluationQuasi-experimentResearch Ethics	2000	2.9K
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) Karl Swedberg, John G.F. Cleland, Henry Dargie, European Heart Journal	2005	2.3K
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland, The Lancet Heart FailureChronic Heart FailureCardiovascular DiseaseClinical TrialsCardiovascular Pharmacology	2003	1.9K
Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival Maarten L. Simoons, Patrick W. Serruys, Marcel van den Brand, Journal of the American College of Cardiology ThrombosisEarly ThrombolysisVenous ThrombosisCardiovascular DiseaseMedicine	1986	504
Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Willem J. Remme, Karl Swedberg European Journal of Heart Failure	2002	454
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION Maarten L. Simoons, Marcel v.d. Brand, C. de Zwaan, The Lancet ThrombosisVenous ThrombosisCardiovascular DiseaseAtherosclerosisMedicine	1985	453
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure Markku S. Nieminen, Juha Akkila, Franz X. Kleber, Journal of the American College of Cardiology Heart FailurePhysiologyNeurohumoral EffectsCardiovascular PharmacologyDiastolic Function	2000	383
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction Bertram Pitt, Gordon H. Williams, Willem J. Remme, Cardiovascular Drugs and Therapy	2001	356

Page 1